News briefing: FDA approves ointment for precancer skin lesions; Takeda nabs priority review for Shire drug
The FDA has cleared a new topical drug for actinic keratosis, a kind of precancer lesion that forms on skin due to chronic exposure to …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
